Back to Search
Start Over
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
- Source :
- JOURNAL OF NEURO-ONCOLOGY, 131(1), 11-20. SPRINGER, Journal of Neuro-Oncology
- Publisher :
- Springer Nature
-
Abstract
- Glioblastoma (GBM) is a highly vascularized and aggressive type of primary brain tumor in adults with dismal survival. Molecular subtypes of GBM have been identified that are related to clinical outcome and response to therapy. Although the mesenchymal type has been ascribed higher angiogenic activity, extensive characterization of the vascular component in GBM subtypes has not been performed. Therefore, we aimed to investigate the differential vascular status and angiogenic signaling levels in molecular subtypes. GBM tissue samples representing proneural IDH1 mutant, classical-like and mesenchymal-like subtypes were analyzed by morphometry for the number of vessels, vessel size and vessel maturity. Also the expression levels of factors from multiple angiogenic signaling pathways were determined. We found that necrotic and hypoxic areas were relatively larger in mesenchymal-like tumors and these tumors also had larger vessels. However, the number of vessels, basement membrane deposition and pericyte coverage did not vary between the subtypes. Regarding signaling patterns the majority of factors were expressed at similar levels in the subtypes, and only ANGPT2, MMP2, TIMP1, VEGFA and MMP9/TIMP2 were higher expressed in GBMs of the classical-like subtype. In conclusion, although morphological differences were observed between the subtypes, the angiogenic signaling status of GBM subtypes seemed to be rather similar. These results challenge the concept of mesenchymal GBMs being more angiogenic than other subclasses. Electronic supplementary material The online version of this article (doi:10.1007/s11060-016-2269-8) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
0301 basic medicine
Pathology
Cancer Research
MMP2
Angiogenesis
Antigens, CD34
HYPOXIA
Cohort Studies
Gonadotropin-Releasing Hormone
0302 clinical medicine
MACROPHAGES
Subtypes
Neovascularization, Pathologic
Brain Neoplasms
Endoglin
Middle Aged
TUMORS
Isocitrate Dehydrogenase
Gene Expression Regulation, Neoplastic
Vascular endothelial growth factor A
Oncology
Neurology
030220 oncology & carcinogenesis
SURVIVAL
GLIOMA
Female
TRIAL
NEWLY-DIAGNOSED GLIOBLASTOMA
Signal Transduction
RADIOTHERAPY
medicine.medical_specialty
IDH1
BEVACIZUMAB
Brain tumor
Clinical Neurology
Biology
Necrosis
03 medical and health sciences
Antigens, Neoplasm
Glioma
medicine
Humans
Carbonic Anhydrase IX
Aged
Mesenchymal stem cell
Subclasses
ADJUVANT TEMOZOLOMIDE
medicine.disease
Actins
030104 developmental biology
Mutation
Laboratory Investigation
Neurology (clinical)
Glioblastoma
Subjects
Details
- Language :
- English
- ISSN :
- 0167594X
- Volume :
- 131
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of Neuro-Oncology
- Accession number :
- edsair.doi.dedup.....5de242d04ea47047f17c3a968a596167
- Full Text :
- https://doi.org/10.1007/s11060-016-2269-8